{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiahybg4jlkqbvyieg3ro7eukhzcx2g5vvma3khbrvtoxwa6hhwgy4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mhtgxg3h2jp2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicno72fjhywmq6v7etvjevr73ufyuohguixey6thf4mrh3ies263i"
    },
    "mimeType": "image/jpeg",
    "size": 271437
  },
  "path": "/news/2026-03-soy-isoflavone-prodrugs-cb1-receptor.html",
  "publishedAt": "2026-03-24T15:10:06.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A research team at National Taiwan University found that abnormal blood flow activates CB1 receptors in endothelial cells, promoting vascular inflammation and dysfunction. Soy-derived isoflavone prodrugs that inhibit CB1 may help protect blood vessels and prevent atherosclerosis.",
  "title": "Soy isoflavone prodrugs target CB1 receptor to protect blood vessels from atherosclerosis"
}